The role of intravenous fluid and electrolyte replacement is increasingly recognised in the clinical management of Ebola virus disease. However, outbreaks typically occur in resource-limited settings where electrolyte measurement may be initially unavailable. Here we highlight potential strategies for empiric fluid and electrolyte therapy based on experience from Sierra Leone.
HuntLGupta-WrightASimmsV. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis2015; 15: 1292–1299.
2.
ClayKJohnstonAMMooreA. Targeted electrolyte replacement in patients with Ebola virus disease. Clin Infect Dis2015; 61: 1030–1031.
3.
QinEBiJZhaoM. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis2015; 61: 491–495.
4.
ChertowDSKleineCEdwardsJK. Ebola virus disease in West Africa—clinical manifestations and management. New Engl J Med2014; 371: 2054–2057.
5.
BahEILamahMCFletcherT. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New Engl J Med2015; 372: 40–47.
6.
WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. New Engl J Med2014; 371: 1481–1495.
7.
FletcherTEFowlerRABeechingNJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med2014; 40: 1936–1939.
8.
SanchezALukwiyaMBauschD. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol2004; 78: 10370–10377.
